Veterinary Professionals
About PROZINC
PROZINC® (protamine zinc recombinant human insulin) was researched and developed specifically for use in veterinary medicine.
FDA-approved for the reduction of hyperglycemia and hyperglycemia-associated clinical signs in cats and dogs with diabetes mellitus, PROZINC provides the appropriate duration of action for your patients. 1,2
With the largest clinical studies demonstrating efficacy and safety in both canine and feline diabetes, you can be confident in the power of PROZINC to maintain glycemic control and reduce clinical signs
1. PROZINC®(protamine zinc recombinant human insulin) [Freedom of Information Summary]. St. Joseph, MO: Boehringer Ingelheim Vetmedica, Inc; 2009.
2. PROZINC®(protamine zinc recombinant human insulin) [Freedom of Information Summary]. Duluth, GA: Boehringer Ingelheim Animal Health USA Inc; 2019.